Vitrolife AB (publ) (OTCMKTS:VTRLY – Get Free Report) shares rose 1.6% on Friday . The stock traded as high as $15.30 and last traded at $15.30. Approximately 15,000 shares were traded during trading, an increase of 3,650% from the average daily volume of 400 shares. The stock had previously closed at $15.0650.
Vitrolife AB (publ) Price Performance
The firm has a 50-day moving average of $16.57 and a 200-day moving average of $15.66.
About Vitrolife AB (publ)
Vitrolife AB (publ) is a Sweden‐based life science company specializing in products and systems for in vitro fertilization (IVF) and assisted reproductive technologies. Founded in 1994 and headquartered in Gothenburg, the company develops, manufactures and markets a comprehensive portfolio of consumables, culture media and instruments that support the entire IVF process, from gamete handling to embryo culture and cryopreservation.
The company’s product range includes embryo culture media, blastocyst media, vitrification solutions and pipetting tools designed to optimize laboratory workflows and improve outcomes for fertility clinics and patients.
Featured Articles
- Five stocks we like better than Vitrolife AB (publ)
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
- How the Rich Retire
Receive News & Ratings for Vitrolife AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitrolife AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
